Eliminating cervical cancer depends on global effort to ensure supply meets demand

(Credit: Unsplash)

This article is brought to you thanks to the collaboration of The European Sting with the World Economic Forum.

Author: Anuradha Gupta, Deputy CEO, Gavi, the Vaccine Alliance


  • COVID-19 has overshadowed the global movement to vaccinate against cervical cancer.
  • Greater access to HPV vaccine is needed, particularly in lower-income countries where demand has outstripped supply.
  • Lessons can be learned from the challenges of implementing the HPV vaccine in order to boost confidence and uptake of COVID-19 vaccines.

The COVID-19 pandemic has taught us something about how to prevent a disease that kills hundreds of thousands of women every year: we need enough vaccines to go around.

Against the backdrop of the worst pandemic in 100 years, the recent launch of a new global movement to defeat another disease may have gone unnoticed. As COVID-19 continues to escalate, demand for vaccines outstrips their initially limited supply and threatens to prolong the pandemic. We now need to ensure vaccine supply doesn’t become the biggest obstacle to this ambitious new global effort of (for the first time in human history) eliminating a cancer.

Cervical cancer is a deadly disease. Globally, it kills one woman every two minutes – more than 300,000 a year, and nearly all of them in low- and middle-income countries. These aren’t numbers: they are mothers, partners, daughters, sisters, friends. They are leaders, coworkers, neighbours, mentors. Every girl deserves protection against this terrible disease. But that’s not possible when there simply isn’t enough vaccine to go around.

As we have seen with COVID-19, once safe, effective vaccines are available, it’s essential that supply meets demand. But supply of vaccines against human papillomavirus (HPV), which protect against nearly all cases of cervical cancer, has been an ongoing challenge. This means that the global distribution of HPV vaccines is inequitable across geography, income and disease burden.

The relative lack of cervical cancer screening and treatment in many lower-income countries makes prevention through immunisation even more crucial than in higher-income countries. Thanks to work by my organisation, Gavi, the Vaccine Alliance, the HPV vaccine is affordable to lower-income countries – $4.50 per dose, compared with $100 in high-income countries. But price doesn’t matter if there’s not enough to buy. Vaccines, Health and healthcare, Gavi

What is the World Economic Forum doing about access to vaccines?

In 2000, Gavi, the Vaccine Alliance was launched at the World Economic Forum’s Annual Meeting in Davos, with an initial pledge of $750 million from the Bill and Melinda Gates Foundation.

The aim of Gavi is to make vaccines more accessible and affordable for all – wherever people live in the world.

Along with saving an estimated 10 million lives worldwide in less than 20 years,through the vaccination of nearly 700 million children, – Gavi has most recently ensured a life-saving vaccine for Ebola.

At Davos 2016, we announced Gavi’s partnership with Merck to make the life-saving Ebola vaccine a reality.

The Ebola vaccine is the result of years of energy and commitment from Merck; the generosity of Canada’s federal government; leadership by WHO; strong support to test the vaccine from both NGOs such as MSF and the countries affected by the West Africa outbreak; and the rapid response and dedication of the DRC Minister of Health. Without these efforts, it is unlikely this vaccine would be available for several years, if at all.

Read more about the Vaccine Alliance, and how you can contribute to the improvement of access to vaccines globally – in our Impact Story.

Lower-income countries provide valuable insights

Since 2012, Gavi has supported the introduction of the HPV vaccine for girls in 21 lower-income countries, with 10 more in the pipeline. Yet the access gap is still far too wide: as of 2020, less than 25% of low-income and less than 30% of lower middle-income countries had introduced the vaccine, compared with 85% of high-income countries. As we’ve learned from the COVID-19 vaccine race, unless sufficient, timely supply of vaccines is distributed equitably, confidence dips, insecurity rises and people in poor countries may not have the same chance at a healthy future.

Since the pandemic began (despite lockdowns) a spike in vaccine hesitancy and misinformation, and a severe contraction in the global economy, lower-income countries have demonstrated extraordinary resilience in the face of unprecedented challenges. In fact, there’s a lot that higher-income countries preparing to deploy COVID-19 vaccines can learn from lower-income countries about introducing a new vaccine in high demand – starting with how to prioritize high-risk individuals and groups.

For example, when lower-income countries were unable to vaccinate several ages at the same time because of paucity of HPV vaccine supply, they had to prioritize a single age. This is exactly what countries are doing now in deploying COVID-19 vaccines, in order to ensure that high-risk individuals, such as health care and other frontline workers, and vulnerable groups are the first to receive the protection they need. Once supply meets demand, that focus can be expanded.

Higher-income countries can also learn from the successes of lower-income countries in building confidence in, boosting demand for, and ensuring high coverage, of new vaccines – from community engagement, to TV dramas, to e-registers. Health professionals, civil society, religious leaders, social media and tech companies are key partners for governments and global health players in the roll-out of HPV vaccines.

Fight against cervical cancer

With the prize of eliminating cervical cancer in mind, in the long-term we may need to think about targeting further to ensure that the people most in need—those whose lives are most at risk—are given priority in the global context. Launched by the World Health Organization in November 2020, the “Global strategy to accelerate the elimination of cervical cancer as a public health problem” frames the fight against cervical cancer as a moral imperative: we must ensure that necessary health services continue despite the pandemic.

As 2021 begins, we can’t afford to lose one more life to a preventable, curable disease. And that means ensuring that a lack of supply of HPV vaccines to lower-income countries does not become the only barrier to this ambitious, but highly feasible, goal of eliminating cervical cancer – for good.

the sting Milestones

Featured Stings

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

How to build a more resilient and inclusive global system

Stopping antimicrobial resistance would cost just USD 2 per person a year

During the coronavirus pandemic, we must fight for LGBTQ rights more than ever

Final preparations for DCX and IFRA Expo 2019, in association with The European Sting

How two colossal Assyrian icons were recreated using digital tech

Libya: EU efforts should focus on protecting migrants, MEPs say

Difficulties of vaccination against COVID-19

EU takes again positive action on migration crisis while Turkey asks for dear favors in exchange for cooperation

Project Manager – 2024

Social media and the lack of information for blood donation

Commission welcomes provisional agreement on the European Climate Law

The EU to bear the cost of eventual sanctions against Russia

Saudi woman seeking asylum in Thailand ‘now in a secure place’ says UNHCR

A 550 km-long mass of rotting seaweed is heading for Mexico’s pristine beaches

Lack of investment and ambition means Youth Guarantee not reaching potential

This is the life of a refugee: the constant destruction and construction of dreams every day

This is where people live the longest in the EU

Nicaragua ‘crisis’ still cause for concern amid murder, torture allegations: Bachelet

This is our chance to completely redefine the meaning of work

European Green Deal: Commission presents actions to boost organic production

Green Deal: measures to step up the fight against global deforestation

These are the countries where most adults still don’t have a smartphone

It’s just electronic cigarette, don’t worry?

Historian Niall Ferguson on what the pandemic means for the global economy, geopolitics – and parties

Coronavirus response: Commission welcomes agreement on crucial VAT relief for vaccines and testing kits

Portuguese Presidency outlines priorities to EP committees

Romanian Presidency priorities discussed in committees

EU is now giving Google new monopolies to the detriment of European citizens and Internet companies

Mexico: UN chief saddened by pipeline blast in which dozens were killed

The 28 EU leaders show contempt for the European Elections results

Thursday’s Daily Brief: ambulance attack in Libya, #GlobalGoals defenders, human rights in Cambodia, Swine Fever

Pay Transparency: Commission proposes measures to ensure equal pay for equal work

This is how drones and other ‘tradetech’ are transforming international trade

Make no mistake: the purpose of business is to serve society

These are the top countries for travel and tourism in 2019

Rare Disease Day: a new EU platform to support better diagnosis and treatment

Spanish and Polish voters are crying out for an imminent European change while US urge now Germany to change route

EU co-ordinating the urgent delivery of COVID-19 vaccines to Moldova

Why global collaboration is needed to protect against a new generation of cyber threats

Does upgrading our minds mean losing the spark of genius?

This Brooklyn farm company is training a new generation of urban farmers

Countries are piling on record amounts of debt amid COVID-19. Here’s what that means

A brief history of cryptography and why it matters

Yemen: €95 million in EU humanitarian aid for people threatened by conflict and famine

Parliament: No consent to EU budget until €11.2 billion unpaid bills are settled

Chinese tech investors are turning towards MENA. Here’s why

Can Obama attract Iran close to the US sphere of influence?

How our Europe will regain its strength: op-ed by Ursula von der Leyen, President of the European Commission

From underestimation to valorization: how mobile technology is transforming global health

The Khashoggi affair: A global complot staged behind closed doors

Safe spaces offer security and dignity for youth, and help make the world ‘better for all’: Guterres

Smart city experts should be looking to emerging markets. Here’s why

Brazil identifies a clear pathway for aligning its transfer pricing framework with the OECD standard

The public health system in Brazil as a promoter of sexual and reproductive health and rights: how does it help in the fight against HIV/AIDS?

Mountains matter, especially if you’re young, UN declares

At G20 Summit OECD’s Gurría says collective action vital to tackle global challenges

Top UN court orders Myanmar to protect Rohingya from genocide

How fungi could save the world

Why South Africa is on a path of economic renewal

Rule of Law: Commission launches infringement procedure to protect the independence of the Polish Supreme Court

Supply chains are on the cusp of a data-fed revolution. Here’s how businesses can succeed.

Global warming: our responsibility

More Stings?

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s